PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institutegrid.1049.c, Brisbane, Queensland, Australia.\', \'Faculty of Medicine, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia.\', \'Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe Universitygrid.1018.8, Melbourne, Victoria, Australia.\', \'Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.\', \'Cancer Precision Medicine Group, QIMR Berghofer Medical Research Institutegrid.1049.c, Herston, Queensland, Australia.\', \'School of Chemistry and Molecular Biosciences, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/spectrum.02780-21
?:hasPublicationType
?:journal
  • Microbiology spectrum
is ?:pmid of
?:pmid
?:pmid
  • 35196796
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.814
?:rankingScore_hIndex
  • 21
is ?:relation_isRelatedTo_publication of
?:title
  • Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all